aluates Reports

$ 0.0

Automative

Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-24C18464

BUY CHAPTERS

Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Research Report 2024

Code: QYRE-Auto-24C18464

Report

December 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly & Co

GE Healthcare Inc

Life Molecular Imaging Ltd.

Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size

The global market for Diagnostic Radiopharmaceuticals for Alzheimer Disease was valued at US$ 200 million in the year 2023 and is projected to reach a revised size of US$ 691 million by 2030, growing at a CAGR of 12.6% during the forecast period.

Diagnostic Radiopharmaceuticals for Alzheimer Disease Market

Radiodrugs for Alzheimer's disease (AD) are A class of radiotracers that are used to label beta-amyloid plaques (Aβ) or tau protein in the brain in positron emission tomography (PET) to assist doctors in early identification of AD, disease classification, and treatment response monitoring.

North American market for Diagnostic Radiopharmaceuticals for Alzheimer Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Diagnostic Radiopharmaceuticals for Alzheimer Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Diagnostic Radiopharmaceuticals for Alzheimer Disease include Eli Lilly & Co., GE Healthcare, Inc., Life Molecular Imaging Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals for Alzheimer Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals for Alzheimer Disease.

The Diagnostic Radiopharmaceuticals for Alzheimer Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Radiopharmaceuticals for Alzheimer Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Radiopharmaceuticals for Alzheimer Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Report

Report Metric	Details
Report Name	Diagnostic Radiopharmaceuticals for Alzheimer Disease Market
Accounted market size in year	US$ 200 million
Forecasted market size in 2030	US$ 691 million
CAGR	12.6%
Base Year	year
Forecasted years	2025 - 2030
by Type	Half Life:1.83 hours Half Life:1 hours
by Application	Hospital Clinic Others
Production by Region	North America Europe
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly & Co., GE Healthcare, Inc., Life Molecular Imaging Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals for Alzheimer Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals for Alzheimer Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Radiopharmaceuticals for Alzheimer Disease Market growing?

Ans: The Diagnostic Radiopharmaceuticals for Alzheimer Disease Market witnessing a CAGR of 12.6% during the forecast period 2025-2030.

What is the Diagnostic Radiopharmaceuticals for Alzheimer Disease Market size in 2030?

Ans: The Diagnostic Radiopharmaceuticals for Alzheimer Disease Market size in 2030 will be US$ 691 million.

Who are the main players in the Diagnostic Radiopharmaceuticals for Alzheimer Disease Market report?

Ans: The main players in the Diagnostic Radiopharmaceuticals for Alzheimer Disease Market are Eli Lilly & Co., GE Healthcare, Inc., Life Molecular Imaging Ltd.

What are the Application segmentation covered in the Diagnostic Radiopharmaceuticals for Alzheimer Disease Market report?

Ans: The Applications covered in the Diagnostic Radiopharmaceuticals for Alzheimer Disease Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Diagnostic Radiopharmaceuticals for Alzheimer Disease Market report?

Ans: The Types covered in the Diagnostic Radiopharmaceuticals for Alzheimer Disease Market report are Half Life:1.83 hours, Half Life:1 hours

Recommended Reports

Alzheimer's Related Drugs

Radiopharmaceuticals Markets

Diagnostic Nuclear Medicine

1 Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Overview

1.1 Product Definition

1.2 Diagnostic Radiopharmaceuticals for Alzheimer Disease by Type

1.2.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Value Comparison by Type (2024-2030)

1.2.2 Half Life:1.83 hours

1.2.3 Half Life:1 hours

1.3 Diagnostic Radiopharmaceuticals for Alzheimer Disease by Application

1.3.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size Estimates and Forecasts

1.4.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue 2019-2030

1.4.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales 2019-2030

1.4.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Competition by Manufacturers

2.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Manufacturers (2019-2024)

2.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Product Type & Application

2.7 Global Key Manufacturers of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Date of Enter into This Industry

2.8 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Competitive Situation and Trends

2.8.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Diagnostic Radiopharmaceuticals for Alzheimer Disease Players Market Share by Revenue

2.8.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Scenario by Region

3.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region: 2019-2030

3.2.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region: 2019-2024

3.2.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region: 2025-2030

3.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region: 2019-2030

3.3.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region: 2019-2024

3.3.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region: 2025-2030

3.4 North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Facts & Figures by Country

3.4.1 North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2030)

3.4.3 North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Facts & Figures by Country

3.5.1 Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2030)

3.5.3 Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Facts & Figures by Region

3.6.1 Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region (2019-2030)

3.6.3 Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Facts & Figures by Country

3.7.1 Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2030)

3.7.3 Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Facts & Figures by Country

3.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2030)

3.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Type (2019-2030)

4.1.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Type (2019-2024)

4.1.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Type (2025-2030)

4.1.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Type (2019-2030)

4.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Type (2019-2030)

4.2.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Type (2019-2024)

4.2.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Type (2025-2030)

4.2.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Type (2019-2030)

4.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price by Type (2019-2030)

5 Segment by Application

5.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Application (2019-2030)

5.1.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Application (2019-2024)

5.1.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Application (2025-2030)

5.1.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Application (2019-2030)

5.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Application (2019-2030)

5.2.1 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Application (2019-2024)

5.2.2 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Application (2025-2030)

5.2.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Application (2019-2030)

5.3 Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Eli Lilly & Co.

6.1.1 Eli Lilly & Co. Company Information

6.1.2 Eli Lilly & Co. Description and Business Overview

6.1.3 Eli Lilly & Co. Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Eli Lilly & Co. Diagnostic Radiopharmaceuticals for Alzheimer Disease Product Portfolio

6.1.5 Eli Lilly & Co. Recent Developments/Updates

6.2 GE Healthcare, Inc.

6.2.1 GE Healthcare, Inc. Company Information

6.2.2 GE Healthcare, Inc. Description and Business Overview

6.2.3 GE Healthcare, Inc. Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GE Healthcare, Inc. Diagnostic Radiopharmaceuticals for Alzheimer Disease Product Portfolio

6.2.5 GE Healthcare, Inc. Recent Developments/Updates

6.3 Life Molecular Imaging Ltd.

6.3.1 Life Molecular Imaging Ltd. Company Information

6.3.2 Life Molecular Imaging Ltd. Description and Business Overview

6.3.3 Life Molecular Imaging Ltd. Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Life Molecular Imaging Ltd. Diagnostic Radiopharmaceuticals for Alzheimer Disease Product Portfolio

6.3.5 Life Molecular Imaging Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Diagnostic Radiopharmaceuticals for Alzheimer Disease Industry Chain Analysis

7.2 Diagnostic Radiopharmaceuticals for Alzheimer Disease Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Diagnostic Radiopharmaceuticals for Alzheimer Disease Production Mode & Process

7.4 Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales and Marketing

7.4.1 Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Channels

7.4.2 Diagnostic Radiopharmaceuticals for Alzheimer Disease Distributors

7.5 Diagnostic Radiopharmaceuticals for Alzheimer Disease Customers

8 Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Dynamics

8.1 Diagnostic Radiopharmaceuticals for Alzheimer Disease Industry Trends

8.2 Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Drivers

8.3 Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Challenges

8.4 Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eli Lilly & Co

GE Healthcare Inc

Life Molecular Imaging Ltd.

List of Tables

Table 1. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Competitive Situation by Manufacturers in 2023

Table 4. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Diagnostic Radiopharmaceuticals for Alzheimer Disease Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Product Type & Application

Table 12. Global Key Manufacturers of Diagnostic Radiopharmaceuticals for Alzheimer Disease, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals for Alzheimer Disease as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region (2019-2024) & (K Units)

Table 18. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Region (2019-2024)

Table 19. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region (2025-2030) & (K Units)

Table 20. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Region (2025-2030)

Table 21. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Region (2019-2024)

Table 23. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Region (2025-2030)

Table 25. North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2024) & (K Units)

Table 27. North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2025-2030) & (K Units)

Table 28. North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2024) & (K Units)

Table 32. Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2025-2030) & (K Units)

Table 33. Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units) by Type (2019-2024)

Table 51. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units) by Type (2025-2030)

Table 52. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Type (2019-2024)

Table 53. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Type (2025-2030)

Table 54. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Type (2019-2024)

Table 57. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Type (2025-2030)

Table 58. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price (US$/Unit) by Type (2019-2024)

Table 59. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price (US$/Unit) by Type (2025-2030)

Table 60. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units) by Application (2019-2024)

Table 61. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units) by Application (2025-2030)

Table 62. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Application (2019-2024)

Table 63. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Application (2025-2030)

Table 64. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Application (2019-2024)

Table 67. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Application (2025-2030)

Table 68. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price (US$/Unit) by Application (2019-2024)

Table 69. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price (US$/Unit) by Application (2025-2030)

Table 70. Eli Lilly & Co. Company Information

Table 71. Eli Lilly & Co. Description and Business Overview

Table 72. Eli Lilly & Co. Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Eli Lilly & Co. Diagnostic Radiopharmaceuticals for Alzheimer Disease Product

Table 74. Eli Lilly & Co. Recent Developments/Updates

Table 75. GE Healthcare, Inc. Company Information

Table 76. GE Healthcare, Inc. Description and Business Overview

Table 77. GE Healthcare, Inc. Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. GE Healthcare, Inc. Diagnostic Radiopharmaceuticals for Alzheimer Disease Product

Table 79. GE Healthcare, Inc. Recent Developments/Updates

Table 80. Life Molecular Imaging Ltd. Company Information

Table 81. Life Molecular Imaging Ltd. Description and Business Overview

Table 82. Life Molecular Imaging Ltd. Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Life Molecular Imaging Ltd. Diagnostic Radiopharmaceuticals for Alzheimer Disease Product

Table 84. Life Molecular Imaging Ltd. Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Diagnostic Radiopharmaceuticals for Alzheimer Disease Distributors List

Table 88. Diagnostic Radiopharmaceuticals for Alzheimer Disease Customers List

Table 89. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Trends

Table 90. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Drivers

Table 91. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Challenges

Table 92. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Diagnostic Radiopharmaceuticals for Alzheimer Disease

Figure 2. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Share by Type: 2023 & 2030

Figure 4. Half Life:1.83 hours Product Picture

Figure 5. Half Life:1 hours Product Picture

Figure 6. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size (2019-2030) & (US$ Million)

Figure 13. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales (2019-2030) & (K Units)

Figure 14. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Average Price (US$/Unit) & (2019-2030)

Figure 15. Diagnostic Radiopharmaceuticals for Alzheimer Disease Report Years Considered

Figure 16. Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Share by Manufacturers in 2023

Figure 17. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Diagnostic Radiopharmaceuticals for Alzheimer Disease Players: Market Share by Revenue in Diagnostic Radiopharmaceuticals for Alzheimer Disease in 2023

Figure 19. Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 22. North America Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Country (2019-2030)

Figure 23. United States Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 26. Europe Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Country (2019-2030)

Figure 27. Germany Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Region (2019-2030)

Figure 34. China Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 42. Mexico Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Diagnostic Radiopharmaceuticals for Alzheimer Disease Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Diagnostic Radiopharmaceuticals for Alzheimer Disease by Type (2019-2030)

Figure 52. Global Revenue Market Share of Diagnostic Radiopharmaceuticals for Alzheimer Disease by Type (2019-2030)

Figure 53. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Diagnostic Radiopharmaceuticals for Alzheimer Disease by Application (2019-2030)

Figure 55. Global Revenue Market Share of Diagnostic Radiopharmaceuticals for Alzheimer Disease by Application (2019-2030)

Figure 56. Global Diagnostic Radiopharmaceuticals for Alzheimer Disease Price (US$/Unit) by Application (2019-2030)

Figure 57. Diagnostic Radiopharmaceuticals for Alzheimer Disease Value Chain

Figure 58. Diagnostic Radiopharmaceuticals for Alzheimer Disease Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024

Global Medications for Alzheimer s Disease Market Research Report 2024

Global Alzheimer s Disease Blood Diagnostic Market Research Report 2024

Global Alzheimer s Disease Blood Test Kit Market Research Report 2024

Global Alzheimer s Disease Diagnosis Market Research Report 2024

Global Radiopharmaceuticals for Diagnosis Market Research Report 2024

Global Alzheimer s Disease Drug Market Insights Forecast to 2030

Global Anti amyloid Drugs Market Research Report 2024

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Alzheimer Treatment Drug Market Research Report 2025

Global Alzheimer s Blood Tests Market Research Report 2024

Global Blood Tests for Alzheimer s Diagnosis Market Research Report 2024

Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024

Global Diagnostic Radiopharmaceuticals Market Research Report 2024

Global Aβ PET Tracer Market Research Report 2024

Global SPECT and PET Radiopharmaceuticals Market Research Report 2024

Global Aβ Monoclonal Antibody Drug Market Research Report 2024

Alzheimer s Disease Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cholinesterase Inhibitors for Alzheimer s Disease Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions